Power Law company profile

Yaoshibang

Health Tech & Medtech · Guangzhou, China · Founded 2015 · IPO 2023 Unicorn

Yaoshibang is a Chinese B2B pharmaceutical trading platform

Valuation

$1.61B

Market cap · 2026

Revenue

$2.46B

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

13 investors on Yaoshibang's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Fosun Group

Series B+ 12 investors entered at this stage

DCM

Co-Power Venture Capital

Green Pine Capital

Pearl River Investment

H Capital

Elevation China Capital

Fosun Venture Capital Investment

Shunwei Capital

SIG China

Baidu

Tiger Global

Ivy Capital

Global footprint

Where Yaoshibang has talent and traffic

Workforce by country

🇨🇳 China · Guangzhou HQ

Book a demo for the full country breakdown

Web traffic by country

190K monthly visits
across markets

🇨🇳 China99.6%

🇯🇵 Japan0.8%

🇺🇸 United States0.8%

🇭🇰 Hong Kong0.2%

🇹🇼 Taiwan0.1%

Top 5 markets shown

Market sentiment

What the market is saying about Yaoshibang

An AI-synthesized read of the highest-engagement posts about Yaoshibang on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Yaoshibang on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles